Stratos Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.84M Sell
11,189
-758
-6% -$177K 0.16% 132
2026
Q1
$2.92M Sell
11,947
-27,552
-70% -$6.42M 0.18% 120
2025
Q4
$8.17M Sell
39,499
-6,408
-14% -$1.27M 0.39% 67
2025
Q3
$8.51M Buy
45,907
+33,048
+257% +$5.66M 0.41% 65
2025
Q2
$1.96M Sell
12,859
-640
-5% -$98.4K 0.1% 206
2025
Q1
$2.24M Sell
13,499
-3,619
-21% -$566K 0.12% 160
2024
Q4
$2.48M Sell
17,118
-7,003
-29% -$1.09M 0.12% 171
2024
Q3
$3.91M Sell
24,121
-635
-3% -$101K 0.18% 125
2024
Q2
$3.62M Buy
24,756
+6,666
+37% +$991K 0.18% 127
2024
Q1
$2.86M Sell
18,090
-17,686
-49% -$2.82M 0.17% 143
2023
Q4
$5.61M Buy
35,776
+553
+2% +$84.8K 0.32% 77
2023
Q3
$5.49M Sell
35,223
-823
-2% -$136K 0.36% 74
2023
Q2
$5.97M Buy
36,046
+28
+0.1% +$4.52K 0.42% 55
2023
Q1
$5.58M Sell
36,018
-4,221
-10% -$682K 0.43% 55
2022
Q4
$7.11M Buy
40,239
+1,519
+4% +$262K 0.59% 31
2022
Q3
$6.33M Sell
38,720
-10,576
-21% -$1.79M 0.67% 25
2022
Q2
$8.75M Buy
49,296
+1,407
+3% +$251K 0.79% 17
2022
Q1
$8.49M Buy
47,889
+67
+0.1% +$11.4K 0.69% 25
2021
Q4
$8.18M Buy
47,822
+2,353
+5% +$385K 0.59% 31
2021
Q3
$7.34M Buy
45,469
+6,782
+18% +$1.16M 0.63% 31
2021
Q2
$6.37M Buy
38,687
+3,463
+10% +$573K 0.56% 31
2021
Q1
$5.79M Buy
35,224
+8,327
+31% +$1.35M 0.61% 33
2020
Q4
$4.23M Buy
26,897
+14,791
+122% +$2.18M 0.58% 42
2020
Q3
$1.8M Buy
12,106
+229
+2% +$33.9K 0.44% 62
2020
Q2
$1.67M Buy
11,877
+3,336
+39% +$486K 0.51% 57
2020
Q1
$1.12M Buy
8,541
+2,100
+33% +$298K 0.79% 26
2019
Q4
$940K Sell
6,441
-5,946
-48% -$806K 0.53% 42
2019
Q3
$1.6M Buy
12,387
+1,773
+17% +$234K 0.61% 37
2019
Q2
$1.48M Buy
10,614
+91
+0.9% +$12.6K 0.59% 34
2019
Q1
$1.47M Buy
10,523
+112
+1% +$15K 0.8% 29
2018
Q4
$1.34M Buy
+10,411
New +$1.45M 0.9% 27

Other funds holding JNJ

Stratos Wealth Advisors's JNJ Position: Q2 2026 in Review

Stratos Wealth Advisors reduced its Johnson & Johnson (JNJ) stake by 6.3% in Q2 2026, selling an estimated $177K and leaving 11,189 shares worth $2.84M. The position accounts for 0.16% of the portfolio, ranked #132.

Stratos Wealth Advisors first reported a position in JNJ in Q4 2018 and has held it in 31 quarters since. The position peaked at $8.75M in Q2 2022. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Stratos Wealth Advisors held 11,189 shares of Johnson & Johnson worth $2.84M as of Q2 2026.
  • Stratos Wealth Advisors sold 758 Johnson & Johnson shares in Q2 2026, an estimated $177K.
  • Johnson & Johnson made up 0.16% of Stratos Wealth Advisors's portfolio in Q2 2026, its #132 holding.
  • Stratos Wealth Advisors first reported a position in Johnson & Johnson in Q4 2018 and has held it in 31 quarters since.
  • Stratos Wealth Advisors's Johnson & Johnson position peaked at $8.75M in Q2 2022.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Stratos Wealth Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.